Insider Trading May 6, 2026 07:31 PM

CoreWeave Chief Strategy Officer Executes $47.5 Million Stock Sale Under Pre-Arranged Plan

Brian Venturo liquidates 374,000 Class A shares amid significant stock price appreciation and ahead of upcoming earnings report.

By Leila Farooq CRWV

Brian M. Venturo, the Chief Strategy Officer at CoreWeave, Inc. (NASDAQ: CRWV), has completed a series of stock sales totaling approximately $47.5 million. The transactions involve 374,000 shares of the company's Class A Common Stock and were carried out on May 4, 2026. These trades were executed in accordance with a Rule 10b5-1 trading plan that had been established previously on November 13, 2025. This divestment occurs against a backdrop of substantial stock performance, with CoreWeave shares seeing a 154% increase over the last year. The current market price for the stock stands at $138.04, appearing just one day before the company is set to release its scheduled earnings report on May 7.

CoreWeave Chief Strategy Officer Executes $47.5 Million Stock Sale Under Pre-Arranged Plan
CRWV

Key Points

  • <strong>Executive Divestment:</strong> CSO Brian Venturo sold 374,000 shares via a pre-planned 10b5-1 strategy, totaling $47.5 million. This impacts the individual executive's equity position and provides insight into internal liquidity timing.
  • <strong>Significant Contractual Growth:</strong> CoreWeave has expanded its performance obligations to over $95 billion through major deals with Meta ($21 billion) and Jane Street ($6 billion), impacting the broader enterprise technology and cloud infrastructure sectors.
  • <strong>Capital Expansion:</strong> The company's $1 billion senior notes offering at a 9.75% interest rate marks a significant move in its financial strategy as it manages growth and debt maturity through 2031.

CoreWeave, Inc. (NASDAQ: CRWV) Chief Strategy Officer Brian M. Venturo has finalized the sale of 374,000 shares of Class A Common Stock. The total value realized from these transactions is estimated at approximately $47.5 million. These sales were conducted on May 4, 2026, following a pre-arranged Rule 10b5-1 trading plan that was adopted by Venturo on November 13, 2025.


The liquidation took place through various transactions with weighted average prices falling between $121.75 and $129.27 per share. The breakdown of the sales shows that 299,000 shares were sold indirectly via West Clay Capital LLC, an entity where Mr. Venturo serves as the managing member; these specific transactions accounted for roughly $37.9 million. Furthermore, 75,000 shares were sold indirectly through the Venturo Family GST Exempt Trust. In this trust, Mr. Venturo's spouse acts as trustee, with his spouse and minor children listed as beneficiaries, resulting in proceeds of approximately $9.6 million.


Before these disposals, Mr. Venturo performed a conversion of 375,000 shares of Class B Common Stock into an equivalent number of Class A Common Stock. This conversion was executed through both West Clay Capital LLC and the Venturo Family GST Exempt Trust. According to the company's Amended and Restated Certificate of Incorporation, Class B Common Stock can be converted into one share of Class A Common Stock at the holder's discretion or automatically under specific predefined conditions.


Following this series of transactions, Mr. Venturo retains a direct holding of 223,580 shares of Class A Common Stock. He also continues to hold various indirect interests in both Class A and Class B Common Stock through several entities, including the Venturo Family GST Exempt Trust, West Clay Capital LLC, YOLO APV Trust, YOLO ECV Trust, and other family-related trusts.


Market Context and Valuation

The timing of these sales follows a period of intense growth for CoreWeave, as shares have surged by 154% over the past year. As of the reporting period, the stock was trading at $138.04. However, valuation metrics suggest caution; analysis indicates that CoreWeave may be overvalued at current levels, noting a high Price/Book multiple of 22.47x.


Recent Corporate Developments

CoreWeave has recently secured several high-value agreements that have impacted its performance obligations, which now exceed $95 billion. These include a $21 billion deal with Meta and a $6 billion agreement with Jane Street. In terms of capital structure, the company also priced a $1 billion senior notes offering featuring a 9.75% interest rate, with a maturity date in 2031.


Financial analysts have responded to these developments with updated outlooks. Jefferies raised its price target for CRWV to $160, pointing toward the company's recent lucrative deals. Similarly, Cantor Fitzgerald increased its price target to $156 following the conclusion of the Jane Street agreement. While the stock recently faced downward pressure due to reports regarding OpenAI's sales targets, CoreWeave has maintained a focus on the diversity of its customer base.

Risks

  • <strong>Valuation Concerns:</strong> With a Price/Book multiple of 22.47x, there is a risk that the stock is currently overvalued, which could impact investor sentiment in the technology sector.
  • <strong>Market Volatility:</strong> Recent share price fluctuations linked to reports on OpenAI's sales targets indicate that external market perceptions of the broader AI and cloud ecosystem can create volatility for CoreWeave.

More from Insider Trading

Travere Therapeutics Executive Executes Over $1 Million in Stock Sales May 6, 2026 Travere Therapeutics Director Executes $360,000 Stock Sale Under Pre-Arranged Plan May 6, 2026 Arcutis Biotherapeutics Executive Disposes of $192,000 in Common Stock May 6, 2026 Ultra Clean Holdings Executive Disposes of Over $848,000 in Shares Amid Strong Market Performance May 6, 2026 Affiliated Managers Group Director Executes Significant Stock Purchase Amid Valuation Shifts May 6, 2026